Guenther RM. Role of nutritional therapy in alcoholism treatment. Int J
Biosoc Res 1983;4:5–18.
Werbach MR. Alcohol craving. Int J Altern Complementary Med
1993;July:32.
Biery JR, Williford JH, McMullen EA. Alcohol craving in rehabilitation:
assessment of nutrition therapy. J Am Diet Assoc 1991;91:463–6.
Cleary JP. Etiology and biological treatment of alcohol addiction. J Neuro
Ortho Med Surg 1985;6:75–7.
Smith RF. A five-year field trial of massive nicotinic acid therapy of
alcoholics in Michigan. J Orthomolec Psychiatry 1974;3:327–31.
O’Halloren P. Pyridine nucleotides in the prevention, diagnosis and
treatment of problem drinkers. West J Surg Obstet Gynecol 1961;69:101–4.
Eriksson CJP. Increase in hepatic NAD level—its effect on the redox
state and on ethanol and acetaldehyde metabolism. Fed Eur Biochem Soc
1974;40:3117–20.
Baker H. A vitamin profile of alcoholism. Int J Vitam Nutr Res
1983;(suppl 24):179.
Schuckit MA. Alcohol and Alcoholism. In: Fauci AS, Braunwald E, Isselbacher
KJ, et al, eds, Harrison’s Principles of Internal Medicine, 14th ed. New York:
McGraw-Hill, 1998, 2503–8.
Norton VP. Interrelationships of nutrition and voluntary alcohol consumption
in experimental animals. Br J Addiction 1977;72:205–12.
Horrobin DF. Essential fatty acids, prostaglandins, and alcoholism: an
overview. Alcohol Clin Exp Res 1987;11:2–9.
Glen I, Skinner F, Glen E, MacDonell L. The role of essential fatty acids in
alcohol dependence and tissue damage. Alcohol Clin Exp Res 1987;11:37–41.
Replogle WH, Eicke FJ. Megavitamin therapy in the reduction of anxiety and
depression among alcoholics. J Orthomolec Med 1988;4:221–4.
Morgan MY, Levine JA. Alcohol and nutrition. Proc Natl Acad Sci
1988;47:85–98.
Chapman K, Prabhudesai M, Erdman JW. Vitamin A status of alcoholics upon
admission and after two weeks of hospitalization. J Am Coll Nutr
1993;12:77–83.
Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse
interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr
1999;69:1071–85 [review].
Chen M, Boyce W, Hsu JM. Effect of ascorbic acid on plasma alcohol clearance.
J Am Coll Nutr 1990;9:185–9.
Blum K. A commentary on neurotransmitter restoration as a common mode of
treatment for alcohol, cocaine and opiate abuse. Integr Psychiatr
1986;6:199–204.
Rogers LL, Pelton RB. Glutamine in the treatment of alcoholism. Q J Stud
Alcohol 1957;18:581–7.
Embry CK, Lippmann S. Use of magnesium sulfate in alcohol withdrawal. Am
Fam Phys 1987;35:167–70.
Wilson A, Vulcano B. A double-blind, placebo-controlled trial of magnesium
sulfate in the ethanol withdrawal syndrome. Alcohol Clin Exp Res
1984;8:542–5.
Leng-Peschlowe. Alchohol-related liver diseases-use of Legalon®. Z
Klin Med 1994;2:22–7.
Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of
silymarin treatment in patients with cirrhosis of the liver. J Hepatol
1989;9:105–13.
Parés A, Planas R, Torres M, et al. Effects of silymarin in alcoholic
patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and
multicenter trial. J Hepatol 1998;28:615–21.
Faulstich H, Jahn W, Wieland T. Silibinin inhibition of amatoxin uptake in the
perfused rat liver. Arzneimittelforschung 1980;30:452–4.
Tuchweber B, Sieck R, Trost W. Prevention by silibinin of phalloidin induced
hepatotoxicity. Toxicol Appl Pharmacol 1979;51:265–75.
Sonnenbichler J, Zetl I. Stimulating influence of a flavonolignan derivative
on proliferation, RNA synthesis and protein synthesis in liver cells. In: Okolicsanyi L,
Csomos G, Crepaldi G eds, Assessment and Management of Hepatobiliary Disease. Berlin:
Springer-Verlag, 1987, 265–72.
Keung W, Vallee B. Daidzin and daidzein suppress free-choice ethanol intake by
Syrian golden hamsters. Proc Natl Acad Sci USA 1993;90:10,008–12.
Shebek J, Rindone JP. A pilot study exploring the effect of kudzu root on the
drinking habits of patients with chronic alcoholism. J Alt Compl Med
2000;6:45–8.